| Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation. | |
| | |
MedLine Citation:
|
PMID: 12107099 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hyperhomocysteinemia (HHcy) is a newly recognized risk factor for myocardial infarction, however, the effect of HHcy on endothelium-dependent flow-induced dilation of coronary arteries is not known. Thus, changes in diameter of small intramural coronary arteries (diameter, approximately 145 microm) isolated from control rats and rats with methionine diet-induced HHcy were investigated by videomicroscopy. Increases in intraluminal flow (from 0 to 40 microl/min) elicited dilations of control vessels (maximum, 25 +/- 2 microm), responses that were absent in HHcy arteries. The nitric oxide (NO) synthase inhibitor L-NAME inhibited flow-induced dilation of control coronaries, whereas it had no effect on responses of HHcy arteries. Dilations of control and HHcy arteries to the NO donor sodium nitroprusside were not different. Responses to flow in HHcy coronary arteries were unaffected by administration of L-arginine or the prostaglandin H(2)/thromboxane A(2) receptor antagonist SQ 29,548. However, in the presence of superoxide dismutase (plus catalase) or the superoxide scavenger Tiron increases in flow elicited L-NAME-sensitive dilations of HHcy coronaries (maximum, 18 +/- 5 microm). Also, superoxide dismutase significantly reduced the enhanced superoxide production of HHcy coronaries (measured by the lucigenin chemiluminescence method). Single vessel Western blotting showed an increased tyrosine nitrosation (a stable biomarker of tissue peroxynitrite formation) in HHcy coronaries. Also, extensive prevalence of 3-nitrotyrosine immunoreactivity was observed in HHcy coronaries that was confined primarily to the subendothelial layers of smooth muscle. We propose that in HHcy an increased level of superoxide scavenges NO forming peroxynitrite, which increases protein nitrosation. The reduced bioavailability of NO impairs flow-induced dilations of coronary arteries, which may contribute to the development of coronary atherosclerosis and ischemic heart disease. |
| | |
Authors:
|
Zoltan Ungvari; Anna Csiszar; Zsolt Bagi; Akos Koller |
Related Documents
:
|
8490289 - Effect of cold stress on coronary sinus blood flow in patients with scleroderma. 1132099 - Influence of hypertonic mannitol on ventricular performance and coronary blood flow in ... 9236429 - Intracoronary angiotensin ii potentiates coronary sympathetic vasoconstriction in humans. 9302359 - Mechanism of coronary microvascular responses to metabolic stimulation. 2963519 - Coronary vasodilatory action after a single dose of nicorandil. 3440269 - Effects of nifedipine on coronary reactive and exercise induced hyperaemia. 22425819 - Cyclosporine treatment improves cardiac function and systemic hemodynamics during resus... 1591839 - Preconditioning does not attenuate myocardial stunning. 4051839 - Nemaline myopathy with associated cardiomyopathy. report of clinical and detailed autop... |
Publication Detail:
|
Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: The American journal of pathology Volume: 161 ISSN: 0002-9440 ISO Abbreviation: Am. J. Pathol. Publication Date: 2002 Jul |
Date Detail:
|
Created Date: 2002-07-10 Completed Date: 2002-08-06 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0370502 Medline TA: Am J Pathol Country: United States |
Other Details:
|
Languages: eng Pagination: 145-53 Citation Subset: AIM; IM |
Affiliation:
|
Department of Pathophysiology, Semmelweis University, Budapest, Hungary. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blotting, Western Coronary Circulation / drug effects, physiology* Coronary Vessels / metabolism Enzyme Inhibitors / pharmacology Hyperhomocysteinemia / pathology, physiopathology* Immunohistochemistry Male NG-Nitroarginine Methyl Ester / pharmacology Nitric Oxide / physiology* Peroxynitrous Acid / biosynthesis, pharmacology Rats Rats, Wistar Superoxides / metabolism Tyrosine / analogs & derivatives*, metabolism Vasodilation* |
| Grant Support | |
ID/Acronym/Agency:
|
HL-46813/HL/NHLBI NIH HHS; P01-1HL-43023/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 10102-43-9/Nitric Oxide; 11062-77-4/Superoxides; 14691-52-2/Peroxynitrous Acid; 3604-79-3/3-nitrotyrosine; 50903-99-6/NG-Nitroarginine Methyl Ester; 55520-40-6/Tyrosine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Blockade of platelet-derived growth factor receptor-beta pathway induces apoptosis of vascular endot...
Next Document: STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers.